Diabetes UK Professional Conference 2019
 
06/03/2019
7:45 am - 8:45 am
8:45 am - 8:55 am8.45 Opening words
8:55 am - 10:25 am
8:55 am - 10:25 am08.55 NHS Diabetes Prevention Programme update
8:55 am - 10:25 am09.10 Patient perspective
8:55 am - 10:25 am09.25 Diabetes remission: The DiRECT way
8:55 am - 10:25 am09.40 Patient perspective
8:55 am - 10:25 am09.55 Diabetes prevention: Can mass treatment be part of the strategy?
8:55 am - 10:25 am10.10 Panel discussion
10:25 am - 11:05 amThe ongoing challenge of hypoglycaemia, a century after the discovery of insulin
11:05 am - 11:35 am
11:05 am - 5:00 pm
11:35 am - 1:05 pm
11:35 am - 1:05 pm11.35 Main clinical outcomes of DiRECT at 2 years
11:35 am - 1:05 pm12.05 Discussion
11:35 am - 1:05 pm12.15 How the body achieves return to normal health
11:35 am - 1:05 pm12.30 Discussion
11:35 am - 1:05 pm12.35 Experience with low energy diets for diabetes remission in primary care: Three perspectives from DiRECT evaluation
11:35 am - 1:05 pm12.55 Discussion
11:35 am - 1:05 pm13.00 General discussion
11:35 am - 1:05 pm
11:35 am - 1:05 pm11.35 Moving towards the nirvana of psychologically informed diabetes services
11:35 am - 1:05 pm11.55 Points of engagement: Blame, shame and security on the frontline?
11:35 am - 1:05 pm12.15 Why the future must involve online interventions
11:35 am - 1:05 pm12.35 The missing link is YOU
11:35 am - 1:05 pm12.55 Panel discussion
11:35 am - 1:05 pm
11:35 am - 1:05 pm11.35 An overview of UK National guidelines and the role of the MDT
11:35 am - 1:05 pm12.00 Practical implications of enteral feeding with diabetes: A dietitian’s perspective
11:35 am - 1:05 pm12.25 Practical implications of enteral feeding with diabetes: A DSN perspective
11:35 am - 1:05 pm12.50 Panel discussion
11:35 am - 12:35 pm
11:35 am - 12:35 pm11.35 Why is retinopathy so important?
11:35 am - 12:35 pm11.55 Latest developments in retinopathy impacting the diabetes team
11:35 am - 12:35 pm12.15 Reintegrating retinopathy into clinical diabetes care: Practical examples from a medical ophthalmology clinic
11:35 am - 12:35 pm
11:35 am - 12:35 pm11.35 The roles of orthopaedic surgery in the integrated care of disease of the foot in diabetes
11:35 am - 12:35 pm12.05 Practical issues involved in the provision of off-loading
11:35 am - 12:35 pm12.20 Data linkage and geospatial mapping exposes inequalities in outcomes for diabetic foot disease in Glasgow
11:35 am - 12:35 pmKindly sponsored by The Boehringer Ingelheim and Lilly Diabetes Alliance.
11:35 am - 1:05 pm
11:35 am - 12:35 pm
12:35 pm - 2:45 pm
1:15 pm - 2:10 pmDietitians
1:15 pm - 2:10 pmEye Specialists
1:15 pm - 2:10 pmPodiatrists
1:15 pm - 2:10 pmPractising Pharmacists
1:15 pm - 2:10 pmPrimary care
1:15 pm - 2:10 pmPsychosocial care
1:15 pm - 1:45 pm
2:45 pm - 3:45 pmKindly sponsored by Mylan
2:45 pm - 3:45 pm
2:45 pm - 3:45 pm14.45 DiRECT: An overview of dietetic input
2:45 pm - 3:45 pm15.00 DiRECT: The GPs eye view
2:45 pm - 3:45 pm15.15 A patient's experience of the DiRECT trial
2:45 pm - 3:45 pm15.30 Panel discussion
2:15 pm - 3:45 pm
2:15 pm - 3:45 pm14.15 NDIA: How broken is it?
2:15 pm - 3:45 pm14.33 Management of challenging patients
2:15 pm - 3:45 pm14.51 Fixing it through technology
2:15 pm - 3:45 pm15.09 Fixing it through systems approaches, resource management and teamwork
2:15 pm - 3:45 pm15.27 Discussion
2:15 pm - 3:45 pm
2:15 pm - 3:45 pm14.15 Type 1 Diabetes TrialNet: An update
2:15 pm - 3:45 pm14.45 A systematic review of therapies to preserve beta cell function: Preliminary results
2:15 pm - 3:45 pm15.15 GPPAD: Launching the UK arm
2:15 pm - 3:45 pm
2:15 pm - 3:45 pm14.15 The challenges in delivering optimal diabetes service pathways in primary care settings, and the collaborative opportunities
2:15 pm - 3:45 pm14.40 Improving diabetes care delivery and evolving service provision trends in primary care settings
2:15 pm - 3:45 pm15.00 Utilising the pharmacy workforce in improving diabetes care delivery, transition of care, and reducing complications: A UK perspective
2:15 pm - 3:45 pm15.20 Transforming diabetes care to improve engagement and achieve results
2:15 pm - 3:45 pm15.40 Panel discussion and questions from the floor
2:45 pm - 3:45 pm
2:45 pm - 3:45 pm14.45 Overview of the service
2:45 pm - 3:45 pm14.55 Practice Base Clinics and supporting practice nurses and GP’s in managing diabetes
2:45 pm - 3:45 pm15.10 Supporting the hard to reach groups across the CCG
2:45 pm - 3:45 pm15.25 What we have achieved, outcomes, and what the future holds
2:45 pm - 3:45 pm15.35 Panel discussion
2:15 pm - 3:45 pm
2:45 pm - 3:45 pm
3:50 pm - 4:30 pmPersonalised nutrition: A route to better public health
4:30 pm - 5:00 pm
4:30 pm - 5:00 pm
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm17.00 Chronic pancreatitis and diabetes: When should we be looking for genetic answers?
5:00 pm - 6:30 pm17.25 Detecting pancreatic cancer in individuals with new-onset diabetes
5:00 pm - 6:30 pm17.50 Diabetes challenges in cystic fibrosis
5:00 pm - 6:30 pm18.15 Panel discussion
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm17.00 Dietary prevention of Type 2 diabetes, current state of the evidence and future research needs
5:00 pm - 6:30 pm17.15 The pros and cons of low carbohydrate diets
5:00 pm - 6:30 pm17.30 A person centred approach to diabetes care: What does the individual need?
5:00 pm - 6:30 pm17.45 Intermittent fasting: Weight-loss and beyond
5:00 pm - 6:30 pm18.00 Panel discussion
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm17.00 Diabetes UK’s interim position statement and nutrition guidelines recommendations
5:00 pm - 6:30 pm17.20 Debate: How do we define remission? Making the case for HbA1c below 48mmol/mol (6.5%)
5:00 pm - 6:30 pm17.45 Debate: How do we define remission? Making the case for HbA1c below 42mmol/mol (6%)
5:00 pm - 6:30 pm18.10 Panel discussion and questions from the floor
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm17.00 Updated assessment of the NHS cost of caring for diabetic foot ulcers
5:00 pm - 6:30 pm17.20 Variation in the incidence of major amputation in England
5:00 pm - 6:30 pm17.35 Update on the impact of the transformation funding initiative
5:00 pm - 6:30 pm17.50 Aspects of the foot care pathway associated with improved outcomes
5:00 pm - 6:30 pm18.05 Annual report of the National Diabetes Foot Care Audit of England and Wales, 2019
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm
5:00 pm - 6:30 pm
6:30 pm - 9:00 pmKindly sponsored by Novo Nordisk
6:30 pm - 9:00 pmHosted by Sanofi
 
07/03/2019
7:45 am - 8:30 am
8:30 am - 9:10 amImproving patient care in monogenic diabetes through research and education
9:10 am - 10:10 am
9:10 am - 10:10 am09.10 Personal journey
9:10 am - 10:10 am09.20 Bridging the transition gap: Squaring the circle
9:10 am - 10:10 am09.40 Simplicity in the challenge: Getting the basics right in young adult diabetes care
9:10 am - 10:10 am10.00 Questions
9:10 am - 10:10 am
9:10 am - 10:10 am9.10 Stem cells for diabetes: Not just transplantation
10:10 am - 10:55 am
10:10 am - 10:55 am
10:15 am - 10:45 am
10:25 am - 2:15 pm
10:55 am - 11:35 amUnravelling mechanisms for Type 2 diabetes from genetics: From bench to bedside
11:40 am - 12:40 pm
11:40 am - 12:40 pm11.40 CGM with MDI
11:40 am - 12:40 pm12.05 CGM with CSII
11:40 am - 12:40 pm12.30 Panel discussion
11:40 am - 12:40 pm
11:40 am - 12:40 pm11.40 Open Source APS: Everything a HCP needs to know
11:40 am - 12:40 pm12.10 Adult perspective: The Derby experience
11:40 am - 12:40 pm12.20 Paediatric perspective
11:40 am - 12:40 pm12.30 Discussion
11:40 am - 1:10 pm
11:40 am - 1:10 pm11.40 Can we accurately predict macrosomia and should this effect timing of birth?
11:40 am - 1:10 pm12.00 Can continuous glucose monitoring reduce the risk of macrosomia: Lessons from the CONCEPTT study
11:40 am - 1:10 pm12.20 The consequences of macrosomia to later life: How real are they?
11:40 am - 1:10 pm12.40 Results from the National Pregnancy in Diabetes (NPID): Are there options for reducing macrosomia?
11:40 am - 1:10 pm13.00 Panel discussion
11:40 am - 1:10 pmKindly sponsored by Novo Nordisk
11:40 am - 1:10 pm
11:40 am - 1:10 pm11.40 Managing Hyperglycaemia in patients with diabetes and chronic kidney disease
11:40 am - 1:10 pm12.10 SGLT2 inhibitors: Effects on nephropathy, deteriorating renal function and glycaemic control
11:40 am - 1:10 pm12.40 GLP-1 analogues: Effects on nephropathy, deteriorating renal function and glycaemic control
11:40 am - 12:40 pm
11:40 am - 1:10 pm
11:40 am - 1:10 pm
11:40 am - 1:10 pm11.40 A user perspective
11:40 am - 1:10 pm11.55 Linking community and specialist diabetes podiatry foot care services
11:40 am - 1:10 pm12.10 Role of specialist diabetes services in the provision of integrated care: The NW London perspective
11:40 am - 1:10 pm12.25 Practicalities of incorporating vascular surgical services into integrated care
11:40 am - 1:10 pm12.40 User experience
11:40 am - 1:10 pm12.50 Panel discussion
12:40 pm - 2:50 pm
1:20 pm - 2:15 pmConsultants and specialist trainees
1:20 pm - 2:15 pmDiabetes Specialist Nurses
1:20 pm - 2:15 pmMidwives
1:20 pm - 2:15 pmPaediatrics
1:20 pm - 2:20 pm
1:20 pm - 2:20 pm13.20 Welcome
1:20 pm - 2:20 pm13.25 The evolvement and expansion of the DICE programme by Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust
1:20 pm - 2:20 pm13.35 Enhancing specialist knowledge for pharmacists to optimise diabetes medication management by NEEDS (North East Essex Diabetes Service)
1:20 pm - 2:20 pm13.45 The DIADEM Project: Improving the management of diabetes and dementia by Sandwell and West Birmingham NHS Trust
1:20 pm - 2:20 pm13.55 Questions
1:20 pm - 2:20 pm14.15 How to enter QiC Diabetes
1:15 pm - 1:38 pm
1:50 pm - 2:20 pm
2:20 pm - 3:20 pmKindly sponsored by Sanofi
2:20 pm - 3:50 pm
2:20 pm - 3:50 pm14.20 Better models of diabetes that enhance opportunities for personalised medicine
2:20 pm - 3:50 pm14.38 Current and future role of pharmacogenetics in precision medicine
2:20 pm - 3:50 pm14.56 Precision targeting of the microbiome in diabetes
2:20 pm - 3:50 pm15.14 Role of clinical phenotyping and biomarkers in precision medicine
2:20 pm - 3:50 pm15.32 Discussion
2:20 pm - 3:50 pm
2:20 pm - 3:50 pm14.20 Binge eating disorders in Type 2 diabetes: What’s the problem and what can we do?
2:20 pm - 3:50 pm14.40 Insulin omission for weight loss: My journey
2:20 pm - 3:50 pm15.00 When is it an eating disorder and what do I do? Perspectives from a children and young person’s diabetes doctor
2:20 pm - 3:50 pm15.20 Psychological patient engagement skills for healthcare professionals
2:20 pm - 3:50 pm15.40 Panel discussion
2:20 pm - 3:50 pm
2:20 pm - 3:50 pm14.20 New therapeutic approaches: The impact of emerging ‘technologies’ on Type 1 diabetes
2:20 pm - 3:50 pm14.45 Adjunct therapy to insulin in Type 1 diabetes: An option for paediatrics?
2:20 pm - 3:50 pm15.10 Does simulation have any place in the management of diabetes in children?
2:20 pm - 3:50 pm15.35 Panel discussion
2:50 pm - 3:50 pm
2:50 pm - 3:50 pm14.50 Introduction
2:50 pm - 3:50 pm14.55 From Warren to the present day
2:50 pm - 3:50 pm15.10 Changing lives of people with Type 1 diabetes: From education to cell therapy
2:50 pm - 3:50 pm15.25 Preventing complications
2:50 pm - 3:50 pm15.40 Closing words
2:20 pm - 3:50 pm
2:50 pm - 3:50 pm
2:50 pm - 3:50 pm
3:55 pm - 4:35 pmThe future of diabetes education
3:55 pm - 4:55 pm
4:35 pm - 5:05 pm
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm17.05 Challenging diabetes in children: Social and biological factors
5:05 pm - 6:35 pm17.25 Diabesity in children with Type 1 diabetes
5:05 pm - 6:35 pm17.40 Is our present approach effective?
5:05 pm - 6:35 pm18.00 What does 'unmotivated' even mean?
5:05 pm - 6:35 pm18.20 Panel discussion
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm17.05 Smoking as a cause of Type 2 diabetes
5:05 pm - 6:35 pm17.35 Smoking cessation interventions and glycaemic control in diabetes
5:05 pm - 6:35 pm18.05 Diabetes complications in smokers with diabetes
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm17.05 Measuring C-peptide in insulin treated diabetes: How to do it?
5:05 pm - 6:35 pm17.35 Measuring C-peptide in insulin treated diabetes: Why do it?
5:05 pm - 6:35 pm18.05 Measuring C-peptide in Type 1 diabetes: What happens when you screen a whole clinic?
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm17.05 Inflammatory cytokines and fibrotic factors in diabetic nephropathy and obesity related kidney disease
5:05 pm - 6:35 pm17.35 Targeting the glomerular vasculature as a treatment for diabetic nephropathy
5:05 pm - 6:35 pm18.05 Mechanism of how bariatric surgery reduces diabetic kidney disease
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm
5:05 pm - 6:35 pm
6:30 pm - 9:00 pmKindly sponsored by MSD
 
08/03/2019
7:45 am - 8:30 am
8:30 am - 9:30 am
8:30 am - 9:30 am8.30 The many causes of ketoacidosis
8:30 am - 9:30 am8.50 Ketoacidosis in other types of diabetes
8:30 am - 9:30 am9.10 Panel discussion
9:30 am - 10:10 amObesity and diabetes: Legacy for the offspring
10:10 am - 10:40 am
10:25 am - 1:00 pm
10:40 am - 12:10 pm
10:40 am - 12:10 pm10.40 Safety of SGLT2is and GLP-1RAs
10:40 am - 12:10 pm11.02 Anti-platelet therapy in diabetes: Which, when and for how long?
10:40 am - 12:10 pm11.24 Adherence / inertia and role of combination therapies
10:40 am - 12:10 pm11.46 CVOT outcome trials: What do they mean for clinical practice?
10:40 am - 12:10 pm
10:40 am - 12:10 pm10.40 Epidemiology, pathophysiology and clinical features
10:40 am - 12:10 pm11.03 Medication and community interventions
10:40 am - 12:10 pm11.26 Devices and other interventions
10:40 am - 12:10 pm11.49 Discussion
10:40 am - 12:10 pm
10:40 am - 12:10 pm10.40 Mechanisms of action of bariatric surgery
10:40 am - 12:10 pm11.10 Importance of the GLP-1 axis for glucose homeostasis after bariatric surgery
10:40 am - 12:10 pm11.40 Mechanisms in disorders of energy balance
10:40 am - 12:10 pm
10:40 am - 12:10 pm
10:40 am - 12:10 pm
10:40 am - 12:10 pm
10:40 am - 12:10 pm10.40 Diabetic ketoacidosis: Mortality, mental health and prevention
10:40 am - 12:10 pm11.30 Clinical cases and discussion
12:10 pm - 1:20 pm
12:10 pm - 12:55 pm
12:20 pm - 1:15 pmResearch nurses
12:30 pm - 1:20 pm
12:30 pm - 1:20 pm12.30 Chair’s introduction
12:30 pm - 1:20 pm12.35 GIRFT and Type 1 Diabetes
12:30 pm - 1:20 pm12.50 Diabetes technology update
12:30 pm - 1:20 pm13.05 Structured education: The new DAFNE curriculum
1:20 pm - 1:35 pm
1:35 pm - 2:15 pmYou can do it! Sharing our experience of improving diabetes care in North West London
2:20 pm - 3:20 pm
2:20 pm - 3:20 pm14.20 Heart failure: What is it, how to prevent it and how to treat it?
2:20 pm - 3:20 pm14.40 Is defining subtypes the best way to individualise care in Type 2 diabetes?
2:20 pm - 3:20 pm15.00 CVD risk management in Type 1: Should we be more aggressive?
2:20 pm - 3:20 pm
2:20 pm - 3:20 pm
2:20 pm - 3:20 pm
2:20 pm - 3:20 pm
2:20 pm - 3:20 pm
3:20 pm